TY - JOUR
T1 - Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis
AU - Shirabe, Ken
AU - Shimada, Mitsuo
AU - Tsujita, Eiji
AU - Aishima, Shin Ichi
AU - Maehara, Shin Ichiroh
AU - Tanaka, Sinji
AU - Takenaka, Kenji
AU - Maehara, Yoshihiko
PY - 2004/4
Y1 - 2004/4
N2 - Background The aim of this study was to clarify prognostic factors and recurrence patterns in patients with node-negative intrahepatic cholangiocarcinoma (IHCC). Methods A retrospective study was performed to review prognostic factors and recurrence patterns (1) in 22 patients with node-negative IHCC after curative hepatic resection and (2) in 49 patients who underwent resection and lymph node dissection for IHCC. In addition to determining the clinicopathologic factors, the investigators also performed immunohistochemical examination of microvessel counts using antihuman CD-31 and antibody. Results The significant poor prognostic factors in node-negative IHCC were the presence of intrahepatic metastasis, portal vein invasion of cancer cells, and high microvessel counts. After multivariate analysis was conducted, the independent poor prognostic factors were the presence of intrahepatic metastases and high microvessel counts. Of 9 patients who had postoperative recurrence of their disease, intrahepatic recurrence was observed in 7 (78 %). Conclusions The factors linked to poor prognosis in IHCC were tumor angiogenesis and the presence of intrahepatic metastasis. Because intrahepatic recurrence was common, regional and adjuvant chemotherapy to the liver may improve the outcome of patients with these risk factors and node-negative IHCC.
AB - Background The aim of this study was to clarify prognostic factors and recurrence patterns in patients with node-negative intrahepatic cholangiocarcinoma (IHCC). Methods A retrospective study was performed to review prognostic factors and recurrence patterns (1) in 22 patients with node-negative IHCC after curative hepatic resection and (2) in 49 patients who underwent resection and lymph node dissection for IHCC. In addition to determining the clinicopathologic factors, the investigators also performed immunohistochemical examination of microvessel counts using antihuman CD-31 and antibody. Results The significant poor prognostic factors in node-negative IHCC were the presence of intrahepatic metastasis, portal vein invasion of cancer cells, and high microvessel counts. After multivariate analysis was conducted, the independent poor prognostic factors were the presence of intrahepatic metastases and high microvessel counts. Of 9 patients who had postoperative recurrence of their disease, intrahepatic recurrence was observed in 7 (78 %). Conclusions The factors linked to poor prognosis in IHCC were tumor angiogenesis and the presence of intrahepatic metastasis. Because intrahepatic recurrence was common, regional and adjuvant chemotherapy to the liver may improve the outcome of patients with these risk factors and node-negative IHCC.
UR - http://www.scopus.com/inward/record.url?scp=1642341316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1642341316&partnerID=8YFLogxK
U2 - 10.1016/j.amjsurg.2003.12.044
DO - 10.1016/j.amjsurg.2003.12.044
M3 - Article
C2 - 15041507
AN - SCOPUS:1642341316
SN - 0002-9610
VL - 187
SP - 538
EP - 542
JO - American Journal of Surgery
JF - American Journal of Surgery
IS - 4
ER -